QCOM vs SPRO · P/E 16, rev $44.28B vs P/E 9.6, rev $48.0M
Qualcomm Incorporated (QCOM) versus Spero Therapeutics Inc (SPRO) — a side-by-side from cached financials, not a winner call.
Qualcomm Incorporated (QCOM) is a semiconductors company listed on US. It is led by Cristiano Amon.
Spero Therapeutics Inc (SPRO) is a biotechnology company listed on NASDAQ.
Latest reported QCOM revenue for 2025-09-28 was $44.28B. Net income was $5.54B. QCOM currently screens at market cap $175.02B and trailing P/E 16.3.
Latest reported SPRO revenue for 2024-12-31 was $48.0M. Net income was -$68.6M. Revenue was down 53.8% from 2023-12-31 to 2024-12-31. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
QCOM currently screens at market cap $175.02B and trailing P/E 16.3. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
Not investment advice. Open the QCOM and SPRO stock pages for the full models.
Not investment advice.